Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
8.7 USD | +1.16% | +2.11% | -18.87% |
05-09 | Transcript : Oncternal Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
05-09 | Oncternal Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.87% | 25.45M | |
+29.83% | 48.16B | |
-0.75% | 41.73B | |
+43.23% | 41.03B | |
-5.31% | 28.77B | |
+10.26% | 25.59B | |
-22.53% | 18.96B | |
+9.23% | 12.92B | |
+28.69% | 12.03B | |
-2.25% | 11.77B |
- Stock Market
- Equities
- ONCT Stock
- News Oncternal Therapeutics, Inc.
- HC Wainwright Upgrades Oncternal Therapeutics to Buy From Neutral, Price Target is $2